What’s New in Review - Archive

Pre-and-Post-Meeting COI Certification Changes in IAR (8/13/2018) Read More
The NIH is reminding the scientific research community of plans to eliminate Appendix materials related to clinical trials for applications submitted to the NIH, AHRQ, or NIOSH for due dates on or after January 25, 2018 (January 12, 2018)
- Clinical trial-related materials will be specified and required in the new PHS Human Subjects and Clinical Trials Information Form and no longer allowed in the Appendix unless specifically stated as required in Section IV.2, Appendix of the funding opportunity announcement (FOA).
The NIH is revising the additional review criteria announced for career development award applications involving clinical trials (December 1, 2017)
- NIH will apply additional scored review criteria to individual career development (K) award applications submitted for due dates on or after January 25, 2018. See NOT-OD-18-109.
The NIH announces new review criteria for Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants involving research experiences in clinical trials (October 6, 2017).
- This notice informs the community of additional review criteria that NIH will apply to Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants if one or more appointed trainees will propose to gain research experience in an ongoing clinical trial led by a mentor or co-mentor, submitted to due dates on or after January 25, 2018. See NOT-OD-17-123.
The NIH announces new review criteria for research project applications involving clinical trials (September 21-2017)
- Additional review questions will be effective for all clinical trial applications for research project grants and cooperative agreements that are submitted for funding consideration for due dates on or after January 25, 2018. For the evaluation of those applications, new questions will be added to the existing review questions, which will not change for research project applications that do not involve clinical trials. Some Program Announcements and Requests for Applications may include FOA-specific questions in addition to those below. See NOT-OD-17-118.
Clinical Trial Requirements for Grants and Contracts (August 17, 2017)
- NIH is launching a series of initiatives that are rolling out in 2017-2018 to enhance the accountability and transparency of clinical research. Learn more about these changes and how they will affect peer review. See the Clinical Trials webpage.
Updated Appendix Policy Eliminates Clinical Trial-Related Materials for Applications Submitted to Due Dates on or After Jan. 25, 2018 (August 17, 2017)
- Since clinical trial-related materials will be required in the new PHS Human Subjects and Clinical Trials Information Form, they will no longer be allowed in the Appendix for due dates on or after January 25, 2018, unless specifically required in the funding opportunity announcement. See NOT-OD-17-098 .

Reducing Duplicate Commons Accounts (July 12, 2017)
Heads up! eRA Commons/IAR users with more than one account will get an email in late July to log in and verify their preferred account. Multiple accounts will be combined into one account, important, for example, for ensuring you get credit for identification of reviewer service for continuous submission.

If an eRA Commons user selects the account that already includes the IAR role as his/her preferred account, there will be no effect. If he/she chooses another account as primary — all of the meetings, review assignments, etc., will be transferred to the account to be kept, and the reviewer will sign in to IAR using the ‘new’ preferred account. See Nexus article.

Citations of Preprints and Interim Research Products (June 19, 2017)
Reviewers may see interim research products, such as preprints, in grant applications, as NIH is encouraging investigators to include these products to speed the dissemination and enhance the rigor of their work. See NOT-OD-17-050 .

Applications submitted for the May 25, 2017 due date and thereafter may include citations to interim research products.
Interim research products are complete, public research products that are not final, and have not undergone peer review prior to posting.
- Common forms are the preprint and preregistered protocol.
- Interim research products may be similar in quality to preliminary data in an application research plan.
The citation must include a Digital Object Identifier, the Object type, and version.
Citations must link to established repositories; citations of website URL’s is not acceptable.
Citations of preprints and interim research products are not acceptable as post-submission materials.

Nov. 18, 2016

July 19, 2016

Reviewer Guidance to Evaluate Sex as a Biological Variable (SABV)